BioScience Health Innovations, Inc. (BHIC)

Price$5.50Cached quote
BHICOTC
Loading local price history

Financial charts

Revenue

Total cash / debt

CashTotal debt

Financial statements

7 annual periodsNewest to oldest
2025202420232022 · Dec 312022 · Aug 3120212020
Revenue$5.7M$1.8M$597,595$69,343$0$0$0
Gross profit$3.2M$1.3M$484,407$59,644———
Gross margin56.97%70.94%81.06%86.01%———
Research & development$161,353$25,908$0————
Operating expenses$2.5M$1.2M$735,907$230,094$91,921$25,610$7,682
Operating income$719,051$87,000−$251,500−$170,450−$91,921−$25,610−$7,682
Operating margin12.64%4.72%−42.09%−245.81%———
EBITDA$719,051$87,000−$251,500−$170,450———
EBITDA margin12.64%4.72%−42.09%−245.81%———
Net income$642,090$87,000−$251,500−$170,450−$83,208−$25,610−$7,682
Net profit margin11.29%4.72%−42.09%−245.81%———
Basic EPSper basic share$0.06$0.01-$0.04-$0.16—$0.00$0.00
Diluted EPSper diluted share$0.06$0.01-$0.04-$0.16—$0.00$0.00

Owners

Reported shareholders

Ownership data is not available for this listing yet.

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.

Community posts

It’s quiet here.

No posts about BHIC yet. Start the conversation.

Write the first post